Join
Live feed
·
INSIDERFilingvia Quantisnow
Sangamo Therapeutics Inc. logo

Head of Research & Technology Davis Gregory D covered exercise/tax liability with 6,708 shares, decreasing direct ownership by 3% to 201,945 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SGMO· Sangamo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMO (Sangamo Therapeutics Inc.) and more on Quantisnow.